TR199902023T2 - Nekrotize edici enteroklitin olus düzeyinin düsürülmesi için yöntem ve bilesimler. - Google Patents
Nekrotize edici enteroklitin olus düzeyinin düsürülmesi için yöntem ve bilesimler.Info
- Publication number
- TR199902023T2 TR199902023T2 TR1999/02023T TR9902023T TR199902023T2 TR 199902023 T2 TR199902023 T2 TR 199902023T2 TR 1999/02023 T TR1999/02023 T TR 1999/02023T TR 9902023 T TR9902023 T TR 9902023T TR 199902023 T2 TR199902023 T2 TR 199902023T2
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- pufas
- necrotizing
- making
- enteroclit
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 230000002956 necrotizing effect Effects 0.000 title 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 3
- 235000021342 arachidonic acid Nutrition 0.000 abstract 2
- 229940114079 arachidonic acid Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 102000002322 Egg Proteins Human genes 0.000 abstract 1
- 108010000912 Egg Proteins Proteins 0.000 abstract 1
- 206010051606 Necrotising colitis Diseases 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 235000013345 egg yolk Nutrition 0.000 abstract 1
- 210000002969 egg yolk Anatomy 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 abstract 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Abstract
Uzun zincirli çoklu-doymamis yagli asitler (PUFAlar), örnegin, esas olarak kolesterol barindirmayan dokosaheksaenoik asit (DHA) ve arakidonik asiti (AA) ihtiva eden enteral formüller ve bu enteral bilesimlerin yapilmasi için bir bilesim anlatilmistir. Daha özel olarak ise, bulus, n-6 ve n-3 uzun zincirli PUFAlar; fosfolipidler ve/veya kolit temin eden bilesimlerin tatbik edilmesiyle nekrotize edici enterokolitin olus düzeyinin düsürülmesi için yöntemlere iliskindir. Yumurta sarisi lipidlerinden elde edilen bilesimler, n-6 ve n-3 uzun zincirli PUFAlari ihtiva ettikleri ve baskin biçimde bir fostidilkolin biçiminde olduklari için bu bulusta tercih edilmektedir. Bu durumun bir sinerjistik etki ettigine inanilmaktadir. Ayni zamanda, gelistirilmis organoleptik ve stabilite özellikleri temin eden bu gibi bir bilesimin yapilmasi için bir islem de anlatilmistir.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80470097A | 1997-02-21 | 1997-02-21 | |
US82531497A | 1997-03-28 | 1997-03-28 | |
US08/943,576 US6080787A (en) | 1997-02-21 | 1997-10-03 | Methods for reducing the incidence of necrotizing enterocolitis |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199902023T2 true TR199902023T2 (tr) | 2001-09-21 |
Family
ID=27420004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/02023T TR199902023T2 (tr) | 1997-02-21 | 1998-02-19 | Nekrotize edici enteroklitin olus düzeyinin düsürülmesi için yöntem ve bilesimler. |
Country Status (24)
Country | Link |
---|---|
US (1) | US6306908B1 (tr) |
EP (1) | EP1039892B1 (tr) |
JP (1) | JP2001516343A (tr) |
CN (1) | CN1200701C (tr) |
AT (1) | ATE265207T1 (tr) |
AU (1) | AU732903B2 (tr) |
BR (1) | BR9807443A (tr) |
CA (1) | CA2281706C (tr) |
DE (1) | DE69823548T2 (tr) |
DK (1) | DK1039892T3 (tr) |
ES (1) | ES2219871T3 (tr) |
HK (1) | HK1034033A1 (tr) |
HU (1) | HUP0300236A3 (tr) |
ID (1) | ID22744A (tr) |
IL (1) | IL131126A (tr) |
NO (1) | NO994052L (tr) |
NZ (1) | NZ337039A (tr) |
PL (1) | PL343902A1 (tr) |
PT (1) | PT1039892E (tr) |
RU (1) | RU2199317C2 (tr) |
SK (1) | SK112399A3 (tr) |
TR (1) | TR199902023T2 (tr) |
TW (1) | TWI230607B (tr) |
WO (1) | WO1998036745A2 (tr) |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121165A0 (en) * | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
US6180671B1 (en) | 1998-03-10 | 2001-01-30 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US20090274660A1 (en) * | 1999-08-17 | 2009-11-05 | Immunopath Profile, Inc. | Pluripotent therapeutic compositions and uses thereof |
US6495599B2 (en) * | 2000-04-13 | 2002-12-17 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses therof |
WO2004028529A1 (en) * | 2002-09-24 | 2004-04-08 | Suntory Limited | Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
WO2004112507A1 (en) * | 2003-06-23 | 2004-12-29 | Nestec S.A. | Infant or follow-on formula |
CA2530170A1 (en) * | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
GB2422373B (en) * | 2003-08-18 | 2008-05-21 | Btg Int Ltd | Treatment of neurodegenerative conditions |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
NZ552118A (en) * | 2004-06-22 | 2010-03-26 | Nutricia Nv | Improvement of barrier integrity in HIV patients with fatty acids |
EP1721611A1 (en) * | 2005-04-21 | 2006-11-15 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1656839A1 (en) * | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
EP1871181B2 (en) * | 2005-04-21 | 2016-12-21 | N.V. Nutricia | Nutritional supplement for hiv patients |
ES2615521T3 (es) | 2005-05-23 | 2017-06-07 | Massachusetts Institute Of Technology | Composiciones que contienen PUFA y métodos de uso de las mismas |
JP2007063219A (ja) * | 2005-09-01 | 2007-03-15 | Juntendo | 新生児壊死性腸炎疾患予防剤 |
US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
WO2007059431A1 (en) * | 2005-11-14 | 2007-05-24 | The Trustees Of Columbia University In The City Of New York | Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
RU2417712C2 (ru) * | 2005-12-23 | 2011-05-10 | Н.В. Нютрисиа | Питательная композиция для младенцев, предназначенная для предупреждения ожирения |
US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
US7867542B2 (en) * | 2006-11-02 | 2011-01-11 | Ach Food Companies, Inc. | Non-flammable release composition |
EP2200443B2 (en) | 2007-09-17 | 2021-06-30 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
CN101896073B (zh) | 2007-10-09 | 2013-11-20 | 酶学技术有限公司 | 用于治疗胃肠道紊乱和促进肠道发育及成熟的脂质组合物 |
UY31410A1 (es) * | 2007-10-30 | 2009-05-29 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
ES2660416T3 (es) | 2007-11-01 | 2018-03-22 | Enzymotec Ltd. | Mezcla de lípidos para la nutrición de bebés |
US8361534B2 (en) * | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
BRPI0820584A2 (pt) * | 2007-12-20 | 2015-07-14 | Abbott Lab | Pó nutricional estável |
EP2100897A1 (en) * | 2008-01-30 | 2009-09-16 | BNLfood Investments SARL | Lecithin based composition and its use in food |
WO2009096772A1 (en) * | 2008-02-01 | 2009-08-06 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
US9737213B1 (en) * | 2009-03-24 | 2017-08-22 | Vioptix, Inc. | Using an oximeter probe to detect intestinal ischemia |
RU2559646C2 (ru) * | 2009-04-01 | 2015-08-10 | Нестек С.А. | Снижение риска ожирения |
TW201112967A (en) * | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
TW201121431A (en) | 2009-12-01 | 2011-07-01 | Abbott Lab | Soy protein-based nutritional formula with superior stability |
TWI492744B (zh) | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
RU2563355C2 (ru) * | 2009-12-08 | 2015-09-20 | Нестек С.А. | Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока |
WO2011090926A1 (en) | 2010-01-19 | 2011-07-28 | Abbott Laboratories | Nutritional formulas containing synbiotics |
ES2481865T3 (es) | 2010-01-29 | 2014-07-31 | Abbott Laboratories | Emulsiones nutricionales que comprenden HMB de calcio |
EP2461704B1 (en) | 2010-01-29 | 2013-10-09 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
EP2397038A1 (en) | 2010-06-21 | 2011-12-21 | Abbott Laboratories | Early programming of brain function through soy protein feeding |
WO2012009426A1 (en) | 2010-07-13 | 2012-01-19 | Abbott Laboratories | High tolerance infant formula including hydrolyzed protein |
EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
WO2012027287A1 (en) | 2010-08-24 | 2012-03-01 | Abbott Laboratories | Nutritional products including pea protein hydrolysates |
EP2984941A1 (en) | 2010-08-24 | 2016-02-17 | Abbott Laboratories | Nutritional products having improved organoleptic properties |
CN103260440B (zh) | 2010-12-29 | 2017-03-29 | 雅培制药有限公司 | 包括含有甘油单酯的脂肪系统的营养型产品 |
US9763970B2 (en) | 2010-12-31 | 2017-09-19 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
CN107019701B (zh) | 2010-12-31 | 2020-07-28 | 雅培制药有限公司 | 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法 |
US20120171166A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
EP2658549B1 (en) | 2010-12-31 | 2020-06-03 | Abbott Laboratories | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
MY166945A (en) | 2010-12-31 | 2018-07-25 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
CN103391783A (zh) | 2010-12-31 | 2013-11-13 | 雅培制药有限公司 | 使用人乳寡糖改善呼吸道健康的方法 |
CN103402376A (zh) | 2010-12-31 | 2013-11-20 | 雅培制药有限公司 | 促进有益细菌生长的中性人乳寡糖 |
ES2825049T3 (es) | 2010-12-31 | 2021-05-14 | Abbott Lab | Oligosacáridos de leche humana para modular inflamación |
WO2013012989A2 (en) | 2011-07-19 | 2013-01-24 | The Trustees Of Columbia University In The City Of New York | Method and system for production of hydrogen and carbon monoxide |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
CN113662199A (zh) | 2011-08-29 | 2021-11-19 | 雅培制药有限公司 | 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖 |
WO2013101516A1 (en) | 2011-12-29 | 2013-07-04 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna |
US20140335259A1 (en) | 2011-12-29 | 2014-11-13 | Abbott Laboratories | Methods for reducing microbial contamination of dryblended powdered nutritional compositions |
SG11201406022YA (en) | 2012-03-27 | 2014-10-30 | Abbott Lab | Methods for modulating cell-mediated immunity using human milk oligosaccharides |
WO2013170189A1 (en) | 2012-05-11 | 2013-11-14 | Abbott Laboratories | Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
DK2708147T3 (da) | 2012-09-14 | 2020-05-18 | Abbott Lab | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose |
ES2572831T3 (es) | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
EP2708146A1 (en) | 2012-09-17 | 2014-03-19 | Abbott Laboratories, Inc. | Nutritional composition for pregnant women with a beneficial glucose and insulin profile |
WO2014078544A1 (en) | 2012-11-14 | 2014-05-22 | Abbott Laboratories | Compositions and methods for improving the long term safety of powdered infant formulas |
WO2014099904A1 (en) | 2012-12-17 | 2014-06-26 | Abbott Laboratories | Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject |
TW201438719A (zh) | 2012-12-18 | 2014-10-16 | Abbott Lab | 改善壓力症狀之母乳寡糖 |
EP2745705A1 (en) | 2012-12-18 | 2014-06-25 | Abbott Laboratories | Nutritional use of human milk oligosaccharides |
WO2014100022A1 (en) | 2012-12-18 | 2014-06-26 | Abbott Laboratories | Dietary oligosaccharides to enhance learning and memory |
EP3469912A1 (en) | 2012-12-20 | 2019-04-17 | Abbott Laboratories | Nutritional formulations using human milk oligosaccharides for modulating inflammation |
EP2745708A1 (en) | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Antidepressant effect of ß-hydroxy-ß-methylbutyrate |
EP2983526A1 (en) | 2013-03-12 | 2016-02-17 | Abbott Laboratories | Composition comprising a multifunctional viscosity modifying agent |
EP2986163B1 (en) | 2013-03-15 | 2017-04-19 | Abbott Laboratories | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein |
EP2986158A1 (en) | 2013-03-15 | 2016-02-24 | Abbott Laboratories | Methods of maintaining and improving muscle function |
US10070643B2 (en) | 2013-03-28 | 2018-09-11 | The Trustees Of Columbia University In The City Of New York | Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation |
US20160136192A1 (en) | 2013-06-10 | 2016-05-19 | Abbott Laboratories | Methods and compositions for enhancing cognitive performance |
WO2015048646A1 (en) | 2013-09-30 | 2015-04-02 | Abbott Laboratories | Protein powder |
IN2015DN03236A (tr) | 2013-10-11 | 2015-10-02 | Abbott Lab | |
CN103558296B (zh) * | 2013-10-18 | 2015-03-04 | 中国农业大学 | 一种基于脂肪酸检测的动物源性饲料原料鉴别方法 |
CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术(上海)有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
US10568896B2 (en) | 2013-11-19 | 2020-02-25 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
EP2888950A1 (en) | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
WO2015105981A2 (en) | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
CN113331426A (zh) | 2014-04-08 | 2021-09-03 | 雅培公司 | 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法 |
DE102015101273A1 (de) | 2015-01-29 | 2016-08-04 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen |
US11510966B2 (en) | 2016-04-15 | 2022-11-29 | Evive Biotechnology (Shanghai) Ltd | Use of IL-22 in treating necrotizing enterocolitis |
RU2665947C1 (ru) * | 2017-07-13 | 2018-09-05 | Атикат Магомедхановна Герейханова | Способ лечения некротического энтероколита |
US20220312814A1 (en) | 2019-06-07 | 2022-10-06 | Abbott Laboratories | Nutritional ingredient with flow and antifoam properties |
US20230149542A1 (en) | 2020-04-06 | 2023-05-18 | Abbott Laboratories | Nutritional formulations for modulating respiratory-induced cytokines |
CN112137998A (zh) * | 2020-10-10 | 2020-12-29 | 上海交通大学医学院附属新华医院 | 一种活性成分在制备防治坏死性小肠结肠炎药物中的应用 |
WO2022177965A1 (en) | 2021-02-16 | 2022-08-25 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2022226311A1 (en) | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
WO2022266058A1 (en) | 2021-06-14 | 2022-12-22 | Abbott Laboratories | Methods and compositions for treating gas |
WO2023159093A1 (en) | 2022-02-16 | 2023-08-24 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2024064327A1 (en) | 2022-09-22 | 2024-03-28 | Abbott Laboratories | Human milk oligosaccharides for enhancing blood-brain barrier function |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0092121B1 (en) | 1982-04-12 | 1987-12-16 | Board Of Regents, The University Of Texas System | Methods and compositions for treating gastro-intestinal ulcer diesease |
US4670285A (en) | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
US4784861A (en) | 1986-11-24 | 1988-11-15 | Cca Industries, Inc. | Weight-control formulation |
US4950656A (en) | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5032585A (en) | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5043329A (en) | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5000975A (en) | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
US5116819A (en) * | 1989-05-05 | 1992-05-26 | Clintec Nutrition Co. | Enteral diet for patients with pulmonary disease |
US5658767A (en) | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
NZ241359A (en) | 1991-01-24 | 1994-08-26 | Martek Corp | Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils |
WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
DE4407939A1 (de) * | 1993-03-15 | 1994-09-22 | Sueddeutsche Kalkstickstoff | Verfahren zur Herstellung von fett- und cholesterinreduzierten pulverförmigen Produkten auf Eibasis |
FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
ES2118629T3 (es) | 1994-10-05 | 1998-09-16 | Milupa Gmbh & Co Kg | Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp |
JPH09201A (ja) * | 1995-06-23 | 1997-01-07 | Akikuni Yakida | 炎症性腸疾患用食品 |
US5917068A (en) | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
US5790138A (en) | 1996-01-16 | 1998-08-04 | Monolithic System Technology, Inc. | Method and structure for improving display data bandwidth in a unified memory architecture system |
-
1998
- 1998-02-19 JP JP53687198A patent/JP2001516343A/ja active Pending
- 1998-02-19 BR BR9807443-1A patent/BR9807443A/pt not_active IP Right Cessation
- 1998-02-19 AU AU61769/98A patent/AU732903B2/en not_active Ceased
- 1998-02-19 IL IL13112698A patent/IL131126A/xx not_active IP Right Cessation
- 1998-02-19 PL PL98343902A patent/PL343902A1/xx unknown
- 1998-02-19 TR TR1999/02023T patent/TR199902023T2/tr unknown
- 1998-02-19 DK DK98906580T patent/DK1039892T3/da active
- 1998-02-19 ES ES98906580T patent/ES2219871T3/es not_active Expired - Lifetime
- 1998-02-19 CN CNB988043726A patent/CN1200701C/zh not_active Expired - Fee Related
- 1998-02-19 ID IDW990897A patent/ID22744A/id unknown
- 1998-02-19 RU RU99119892/14A patent/RU2199317C2/ru not_active IP Right Cessation
- 1998-02-19 EP EP98906580A patent/EP1039892B1/en not_active Revoked
- 1998-02-19 WO PCT/US1998/003235 patent/WO1998036745A2/en active Search and Examination
- 1998-02-19 CA CA002281706A patent/CA2281706C/en not_active Expired - Fee Related
- 1998-02-19 PT PT98906580T patent/PT1039892E/pt unknown
- 1998-02-19 DE DE69823548T patent/DE69823548T2/de not_active Revoked
- 1998-02-19 NZ NZ337039A patent/NZ337039A/en unknown
- 1998-02-19 AT AT98906580T patent/ATE265207T1/de not_active IP Right Cessation
- 1998-02-19 SK SK1123-99A patent/SK112399A3/sk unknown
- 1998-02-19 HU HU0300236A patent/HUP0300236A3/hu unknown
- 1998-04-03 TW TW087102492A patent/TWI230607B/zh not_active IP Right Cessation
-
1999
- 1999-08-23 NO NO994052A patent/NO994052L/no not_active Application Discontinuation
-
2000
- 2000-05-12 US US09/570,299 patent/US6306908B1/en not_active Expired - Lifetime
-
2001
- 2001-03-29 HK HK01102292A patent/HK1034033A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1039892E (pt) | 2004-09-30 |
RU2199317C2 (ru) | 2003-02-27 |
AU732903B2 (en) | 2001-05-03 |
JP2001516343A (ja) | 2001-09-25 |
NO994052L (no) | 1999-10-20 |
IL131126A0 (en) | 2001-01-28 |
ID22744A (id) | 1999-12-09 |
WO1998036745A3 (en) | 2002-10-03 |
DE69823548D1 (de) | 2004-06-03 |
CA2281706C (en) | 2008-08-05 |
DE69823548T2 (de) | 2005-02-24 |
NZ337039A (en) | 2001-06-29 |
BR9807443A (pt) | 2000-04-25 |
ES2219871T3 (es) | 2004-12-01 |
AU6176998A (en) | 1998-09-09 |
CN1200701C (zh) | 2005-05-11 |
CA2281706A1 (en) | 1998-08-27 |
WO1998036745A2 (en) | 1998-08-27 |
PL343902A1 (en) | 2001-09-10 |
EP1039892B1 (en) | 2004-04-28 |
HUP0300236A2 (hu) | 2003-06-28 |
SK112399A3 (en) | 2000-12-11 |
TWI230607B (en) | 2005-04-11 |
NO994052D0 (no) | 1999-08-23 |
US6306908B1 (en) | 2001-10-23 |
ATE265207T1 (de) | 2004-05-15 |
IL131126A (en) | 2003-04-10 |
HK1034033A1 (en) | 2001-10-12 |
EP1039892A2 (en) | 2000-10-04 |
HUP0300236A3 (en) | 2003-09-29 |
CN1269718A (zh) | 2000-10-11 |
DK1039892T3 (da) | 2004-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199902023T2 (tr) | Nekrotize edici enteroklitin olus düzeyinin düsürülmesi için yöntem ve bilesimler. | |
Narisawa et al. | Colon cancer prevention with a small amount of dietary perilla oil high in alpha‐linolenic acid in an animal model | |
BRPI0709497A2 (pt) | produtos alimentìcios compreendendo ácidos graxos poliinsaturados de cadeia longa e métodos para prepará-los | |
JPH0649479A (ja) | ω−3不飽和脂肪酸系化合物の安定化法 | |
WO2009105620A1 (en) | Selective short chain monounsaturated oils | |
RU2332445C2 (ru) | Антиоксидантная жировая или масляная композиция со стабильным вкусом | |
Cho et al. | Oxidative stability of lipids from squid tissues | |
JPS60105471A (ja) | 健康食品卵の生産方法 | |
DK1027831T3 (da) | Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne | |
JPH05140584A (ja) | 多価不飽和脂肪酸配合油脂の臭気抑制方法 | |
RU2099400C1 (ru) | Способ стабилизации полиненасыщенных соединений трижды и более высокоэтиленово-ненасыщенных органических материалов, композиция на их основе и композиция антиокислителя на их основе | |
US6428461B1 (en) | Method for inhibiting oxidation of polyunsaturated lipids | |
US20030149118A1 (en) | Method and composition which inhibits the oxidation of omega-3 and omega-6 polyunsaturated lipids | |
JP2905275B2 (ja) | 酸化防止剤組成物 | |
CA2713259C (en) | Lecithin based composition and its use in food | |
JP6421252B2 (ja) | 油脂組成物及び油脂の酸化抑制方法 | |
US1938999A (en) | Retardation of rancidity in vegetable food-stuffs | |
Fujita et al. | Increase in the oxidative stability of sardine lipids through heat treatment | |
JPH02208390A (ja) | 抗酸化剤組成物 | |
Jacobsen et al. | Application of functional lipids in foods | |
RU2318014C1 (ru) | Состав для стабилизации липидов | |
WO2021148777A1 (en) | Synergistic compositions | |
Awad et al. | Dietary fat and phospholipase A2 activity of Sprague-Dawley rat large intestine | |
JP2001164286A (ja) | 油脂組成物 | |
JPH03108443A (ja) | 調理用油脂組成物 |